Advanced Biomed Inc. Common Stock (ADVB) vs CNS Pharmaceuticals, Inc. (CNSP)
A side-by-side comparison of Advanced Biomed Inc. Common Stock and CNS Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ADVB
Advanced Biomed Inc. Common Stock
$6.44HealthcareDelayed quote: Oct 6, 2026, 2:45 PM EDT
CNSP
CNS Pharmaceuticals, Inc.
$5.31HealthcareDelayed quote: Oct 6, 2026, 2:53 PM EDT
Total return — ADVB vs CNSP
growth of $100 · dividends reinvested · last 2yADVB -91.3% (-70.5%/yr)CNSP -84.1% (-60.1%/yr)CNSP compounded faster over this window
ADVB CNSP
ADVB vs CNSP: by the numbers
- •ADVB is the larger company ($9M vs $8M market cap).
Metrics side by side
Valuation
| Metric | ADVB | CNSP |
|---|---|---|
| P/B ratio | 0.97 | 0.43 |
Profitability
| Metric | ADVB | CNSP |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -7.36% | -91.75% |
| ROIC | -11.06% | -92.94% |
Growth (annualized)
| Metric | ADVB | CNSP |
|---|---|---|
| Total return CAGR (5Y) | N/A | -91.63% |
Go deeper
Dig into the metrics
Advanced Biomed Inc. Common Stock ROECNS Pharmaceuticals ROEAdvanced Biomed Inc. Common Stock operating marginCNS Pharmaceuticals operating marginAdvanced Biomed Inc. Common Stock revenue growthCNS Pharmaceuticals revenue growthAdvanced Biomed Inc. Common Stock free cash flowCNS Pharmaceuticals free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.